Feline exocrine pancreatic insufficiency : a retrospective study of 150 cases
dc.contributor.author | Xenoulis, P.G. | |
dc.contributor.author | Zoran, D.L. | |
dc.contributor.author | Fosgate, Geoffrey Theodore | |
dc.contributor.author | Suchodolski, J.S. | |
dc.contributor.author | Steiner, J.M. | |
dc.date.accessioned | 2017-01-23T08:13:18Z | |
dc.date.available | 2017-01-23T08:13:18Z | |
dc.date.issued | 2016-11 | |
dc.description | Some of the results of this study were presented at the 2012 American College of Veterinary Internal Medicine Forum, New Orleans, LA. | en_ZA |
dc.description.abstract | BACKGROUND : Little information is available about the clinical presentation and response to treatment of cats with exocrine pancreatic insufficiency (EPI). OBJECTIVES : To describe the signalment, clinical signs, concurrent diseases, and response to treatment of cats with EPI. ANIMALS : One hundred and fifty cats with EPI. METHODS : Retrospective case series. RESULTS : Questionnaires were sent to 261 veterinarians, and 150 (57%) were returned with data suitable for statistical analysis. The median age of the cats with EPI was 7.7 years. The median body condition score was 3 of 9. Ninety-two of 119 cats (77%) had hypocobalaminemia, and 56 of 119 cats (47%) had increased and 6 of 119 cats (5%) had decreased serum folate concentrations. Clinical signs included weight loss (91%), unformed feces (62%), poor hair coat (50%), anorexia (45%), increased appetite (42%), lethargy (40%), watery diarrhea (28%), and vomiting (19%). Eighty-seven cats (58%) had concurrent diseases. Treatment response was reported to be good in 60%, partial in 27%, and poor in 13% of 121 cats. Trypsin-like immunoreactivity <4 lg/L was associated with a positive response to treatment (OR, 3.2; 95% CI, 1.5–7.0; P = .004). Also, cobalamin supplementation improved the response to treatment (OR, 3.0; 95% CI, 1.4–6.6; P = .006). CONCLUSIONS AND CLINICAL IMPORTANCE : Exocrine pancreatic insufficiency in cats often has a different clinical presentation than in dogs. The age range for EPI in cats is wide, and many cats can be ≤5 years of age. Most cats respond well to appropriate treatment for EPI, and cobalamin supplementation appears to be necessary for a good response. | en_ZA |
dc.description.department | Production Animal Studies | en_ZA |
dc.description.librarian | am2017 | en_ZA |
dc.description.uri | http://www.sherpa.ac.uk/romeo/issn/0891-6640/ | en_ZA |
dc.identifier.citation | Xenoulis, PG, Zoran, DL, Fosgate, GT, Suchodolski, JS & Steiner, JM 2016, 'Feline exocrine pancreatic insufficiency : a retrospective study of 150 cases', Journal of Veterinary Internal Medicine, 30, no. 6, pp. 1790-1797. | en_ZA |
dc.identifier.issn | 0891-6640 (print) | |
dc.identifier.issn | 1939-1676 (online) | |
dc.identifier.other | 10.1111/jvim.14560 | |
dc.identifier.uri | http://hdl.handle.net/2263/58596 | |
dc.language.iso | en | en_ZA |
dc.publisher | Wiley | en_ZA |
dc.rights | © 2016 The Authors. This article is published under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). | en_ZA |
dc.subject | Cobalamin | en_ZA |
dc.subject | Treatment | en_ZA |
dc.subject | Exocrine pancreatic insufficiency (EPI) | en_ZA |
dc.subject | Signalment | en_ZA |
dc.subject | Clinical signs | en_ZA |
dc.subject | Concurrent diseases | en_ZA |
dc.subject | Cats | en_ZA |
dc.title | Feline exocrine pancreatic insufficiency : a retrospective study of 150 cases | en_ZA |
dc.type | Article | en_ZA |